CA 2024 * | 54,97 Md 50,81 Md 49,83 Md | CA 2025 * | 58 Md 53,62 Md 52,58 Md | Capitalisation | 285 Md 264 Md 259 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 7,74 Md 7,15 Md 7,02 Md | Résultat net 2025 * | 10,65 Md 9,84 Md 9,65 Md | VE / CA 2024 * | 6,17 x |
Dette nette 2024 * | 53,62 Md 49,57 Md 48,61 Md | Dette nette 2025 * | 47,29 Md 43,72 Md 42,87 Md | VE / CA 2025 * | 5,73 x |
PER 2024 * |
31,4
x | PER 2025 * |
24,1
x | Employés | - |
Rendement 2024 * |
3,82% | Rendement 2025 * |
4,02% | Flottant | 96,37% |
Dernier transcript sur AbbVie
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01/01/13 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 01/01/13 |
Robert Michael
PSD | President | 53 | 01/01/12 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 01/01/13 |
Edward Rapp
BRD | Director/Board Member | 66 | 01/01/13 |
Director/Board Member | 70 | 01/01/13 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
FIDELITY SUST GLB HLTHCARE A-ACC-EUR | Non | 61.23M EUR | +1,00% | |
EURIZON EQUITY WORLD SMART VOL R ACC | Non | 13.7M EUR | +13,00% | |
BGF WORLD HEALTHSCIENCE A2 | Non | 417.49M USD | -2,00% | |
JANUS HENDERSON GLB LIFE SCN I2 USD | Non | 87.56M USD | 0,00% | |
AXA IM US ENHANCED INDEX EQ QI M $ ACC | Non | 25.07M USD | +19,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+31,06% | 682 Md | |
+30,35% | 586 Md | |
-3,42% | 364 Md | |
+18,02% | 327 Md | |
+15,53% | 240 Md | |
+10,16% | 209 Md | |
-8,14% | 203 Md | |
+8,12% | 165 Md | |
-1,42% | 161 Md |